MabVax Therapeutics Overview
- Year Founded
-
2006
- Status
-
Acquired/Merged
- Employees
-
6
- Latest Deal Type
-
M&A
MabVax Therapeutics General Information
Description
MabVax Therapeutics Holdings Inc is a development-stage biopharmaceutical company works to discover, develop, and commercialize small molecule drugs to treat cancer-related illnesses. The company has discovered a pipeline of human monoclonal antibody products based on the protective immune responses generated by patients who have been vaccinated against targeted cancers with theie proprietary vaccines. Its pipeline include Therapeutic(MVT-5873), Radioimmunotherapy(MVT-1075), HuMab-Tn and others.
Contact Information
Website
www.mabvax.comCorporate Office
- 11535 Sorrento Valley Road
- Suite 400
- San Diego, CA 92121
- United States
Corporate Office
- 11535 Sorrento Valley Road
- Suite 400
- San Diego, CA 92121
- United States
MabVax Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 17. Merger/Acquisition | 08-May-2018 | Completed | Generating Revenue | |||
| 16. PIPE | 22-Aug-2017 | Completed | Generating Revenue | |||
| 15. PIPE | 22-May-2017 | Completed | Generating Revenue | |||
| 14. Debt - General | 19-Jan-2016 | Completed | Generating Revenue | |||
| 13. PIPE | 01-Oct-2015 | Completed | Generating Revenue | |||
| 12. PIPE | 10-Apr-2015 | Completed | Generating Revenue | |||
| 11. Reverse Merger | 08-Jul-2014 | Completed | Generating Revenue | |||
| 10. Later Stage VC (Series C1) | 01-Jul-2014 | Completed | Generating Revenue | |||
| 9. Later Stage VC (Series C) | 13-Feb-2014 | $12.1M | $25.9M | Completed | Generating Revenue | |
| 8. Grant | 01-Jan-2014 | $400K | $13.8M | Completed | Generating Revenue |
MabVax Therapeutics Comparisons
Industry
Financing
Details
MabVax Therapeutics Competitors (82)
One of MabVax Therapeutics’s 82 competitors is Inovio Pharmaceuticals, a Corporation company based in Plymouth Meeting, PA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Inovio Pharmaceuticals | Corporation | Plymouth Meeting, PA | ||||
| Ayala Pharmaceuticals | Corporation | Wilmington, DE | ||||
| Marengo Therapeutics | Venture Capital-Backed | Cambridge, MA | ||||
| Adaptimmune Therapeutics | Formerly VC-backed | Abingdon, United Kingdom | ||||
| Iovance Biotherapeutics | Corporation | San Carlos, CA |
MabVax Therapeutics Patents
MabVax Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-11707522-B2 | Human antibodies to tn antigen | Active | 13-Oct-2017 | ||
| US-20190111164-A1 | Human antibodies to tn antigen | Active | 13-Oct-2017 | ||
| WO-2015187811-A2 | Human monoclonal antibodies to ganglioside gd2 | Inactive | 04-Jun-2014 | ||
| WO-2015187811-A3 | Human monoclonal antibodies to ganglioside gd2 | Inactive | 04-Jun-2014 | ||
| JP-2019047821-A | Nucleic acids encoding human antibodies to sialyl-lewis a | Active | 26-Aug-2013 | C07K16/2896 |
MabVax Therapeutics Signals
MabVax Therapeutics Former Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Biomark Capital | PE/Buyout | Minority | ||
| Burrill & Co | Merchant Banking Firm | Minority | ||
| Numoda Capital Innovations | Venture Capital | Minority | ||
| OPKO Health | Corporation | Minority | ||
| Solving Kids Cancer Foundation | Corporation |
MabVax Therapeutics Acquisitions (1)
MabVax Therapeutics’s most recent deal was a Merger/Acquisition with Telik. The deal was made on 09-Jul-2014.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Telik | 09-Jul-2014 | Merger/Acquisition | Drug Discovery |
MabVax Therapeutics FAQs
-
When was MabVax Therapeutics founded?
MabVax Therapeutics was founded in 2006.
-
Where is MabVax Therapeutics headquartered?
MabVax Therapeutics is headquartered in San Diego, CA.
-
What is the size of MabVax Therapeutics?
MabVax Therapeutics has 6 total employees.
-
What industry is MabVax Therapeutics in?
MabVax Therapeutics’s primary industry is Drug Discovery.
-
Is MabVax Therapeutics a private or public company?
MabVax Therapeutics is a Private company.
-
What is MabVax Therapeutics’s current revenue?
The current revenue for MabVax Therapeutics is .
-
How much funding has MabVax Therapeutics raised over time?
MabVax Therapeutics has raised $61.2M.
-
Who are MabVax Therapeutics’s investors?
Biomark Capital, Burrill & Co, Numoda Capital Innovations, OPKO Health, and Solving Kids Cancer Foundation are 5 of 6 investors who have invested in MabVax Therapeutics.
-
Who are MabVax Therapeutics’s competitors?
Inovio Pharmaceuticals, Ayala Pharmaceuticals, Marengo Therapeutics, Adaptimmune Therapeutics, and Iovance Biotherapeutics are some of the 82 competitors of MabVax Therapeutics.
-
When was MabVax Therapeutics acquired?
MabVax Therapeutics was acquired on 08-May-2018.
-
Who acquired MabVax Therapeutics?
MabVax Therapeutics was acquired by BioNTech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process